Fireside Chat on Clinical Trial Abundance with Adam Kroetsch and CompBio@Berkeley

​​At Students for Abundance, we rarely get to talk about scientific output and the barriers to innovation. What policy levers does the NIH, FDA, and, more broadly, the government have over biomedical research & drug innovation?

Please join Students for Abundance and CompBio @ Berkeley for a conversation with Adam Kroetsch, blogger at Clinical Trials Abundance.